Clinical trials
Recruiting Psoriasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
121 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 11 |
| 2023 | 10 |
| 2024 | 9 |
| 2025 | 44 |
| 2026 | 24 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 121 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 6 |
| Psoriasis Treatment Center of Central New Jersey | 5 |
| CorEvitas | 4 |
| Centre Hospitalier Universitaire de Nice | 3 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 |
| Xijing Hospital | 3 |
| Almirall, S.A. | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Cairo University | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psoriasis | 121 |
| Arthritis, Psoriatic | 18 |
| Dermatitis, Atopic | 16 |
| Crohn Disease | 8 |
| Colitis, Ulcerative | 7 |
| Autoimmune Diseases | 6 |
| Inflammatory Bowel Diseases | 6 |
| Arthritis, Rheumatoid | 5 |
| Hidradenitis Suppurativa | 5 |
| Spondylitis, Ankylosing | 5 |
Trials
Showing 51 to 75 of 121. Each trial links to its page on Pharma Observatory.
21 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.